Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycythemia Vera × Drug Evaluation × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Lymphoma, Non-Hodgkin 2 Colorectal Neoplasms 2 Carcinoma, Basal Cell 2 Basal Cell Nevus Syndrome 2 Upper Tract Urothelial Carcinomas 1 Thrombocythemia, Essential 1 Solid Tumors 1 Serous Ovarian Cancer 1 Recurrence 1 Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 Polycythemia Vera 1 Lymphedema 1 Liver Neoplasms 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hypogonadism 1 Glioma 1 Fatigue Syndrome, Chronic 1 Fallopian Tube Neoplasms 1 Eunuchism 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Amyloidosis 1 Adenoma 1

Interventions

ruxolitinib 27 fludarabine phosphate 27 Peripheral Blood Stem Cell Transplantation 22 Cyclophosphamide 22 Busulfan 17 Whole-Body Irradiation 14 Mycophenolic Acid 13 Tacrolimus 12 Cyclosporine 11 Methotrexate 10 Antilymphocyte Serum 10 fludarabine 8 Hydroxyurea 8 Aspirin 8 Melphalan 7 Filgrastim 7 Etoposide 7 Decitabine 7 Cytarabine 6 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6 peginterferon alfa-2a 5 givinostat hydrochloride 5 givinostat 5 Radiotherapy 5 Biopsy 5 Stem Cell Transplantation 4 Prednisone 4 Phlebotomy 4 Methylprednisolone 4 Imatinib Mesylate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577926 2025-06-10

Ruxo-BEAT

RWTH Aachen University

Phase 2 Active not recruiting

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon ⚡